Development and Characterization of a Reverse Genetics System for a Human-Derived Severe Fever With Thrombocytopenia Syndrome Virus Isolate From South Korea

Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging, tick-borne Bandavirus that causes lethal disease in humans. As there are no licensed vaccines and therapeutics for SFTSV, there is an urgent need to develop countermeasures against it. In this respect, a reverse genetics (RG) system is a powerful tool to help achieve this goal. Herein, we established a T7 RNA polymerase-driven RG system to rescue infectious clones of a Korean SFTSV human isolate entirely from complementary DNA (cDNA). To establish this system, we cloned cDNAs encoding the three antigenomic segments into transcription vectors, with each segment transcribed under the control of the T7 promoter and the hepatitis delta virus ribozyme (HdvRz) sequences. We also constructed two helper plasmids expressing the nucleoprotein (NP) or viral RNA-dependent RNA polymerase (RdRp) under the control of the T7 promoter and the encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES). After co-transfection into BHK/T7-9 cells with three transcription and two helper plasmids, then passaging in Vero E6 or Huh-7 cells, we confirmed efficient rescue of the recombinant SFTSV. By evaluating the in vitro and in vivo virological properties of the parental and rescued SFTSVs, we show that the rescued virus exhibited biological properties similar to those of the parental virus. This system will be useful for identifying molecular viral determinants of SFTSV infection and pathogenesis and for facilitating the development of vaccine and antiviral approaches.

[1]  Steven B. Bradfute,et al.  2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. , 2020, Archives of virology.

[2]  M. Shimojima,et al.  Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration , 2018, bioRxiv.

[3]  Su-Jin Park,et al.  Molecular genomic characterization of tick- and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea , 2017, PLoS neglected tropical diseases.

[4]  H. Ebihara,et al.  Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection , 2017, Front. Microbiol..

[5]  Haruo Watanabe,et al.  Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus , 2016, mSphere.

[6]  S. Choi,et al.  Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Taesoo Kwon,et al.  Full-Genome Sequences of Severe Fever with Thrombocytopenia Syndrome Virus, Isolated from South Korea in 2014 , 2015, Genome Announcements.

[8]  R. Elliott,et al.  Reverse Genetics System for Severe Fever with Thrombocytopenia Syndrome Virus , 2014, Journal of Virology.

[9]  Weizhong Yang,et al.  Risk Factors for Bunyavirus-Associated Severe Fever with Thrombocytopenia Syndrome, China , 2014, PLoS neglected tropical diseases.

[10]  B. He,et al.  Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. , 2014, The Lancet. Infectious diseases.

[11]  M. Shimojima,et al.  The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan , 2013, The Journal of infectious diseases.

[12]  P. G. Choe,et al.  Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012 , 2013, Emerging infectious diseases.

[13]  Yuna Sun,et al.  Structural perspective on the formation of ribonucleoprotein complex in negative-sense single-stranded RNA viruses. , 2013, Trends in microbiology.

[14]  Bian-Li Xu,et al.  Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. , 2013, The Journal of infectious diseases.

[15]  Jinjing Zou,et al.  A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[16]  Qun Li,et al.  Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. , 2012, Vector borne and zoonotic diseases.

[17]  Z. Bi,et al.  Person-to-Person Transmission of Severe Fever With Thrombocytopenia Syndrome Bunyavirus Through Blood Contact , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Klena,et al.  A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Yuan Zhang,et al.  Metagenomic Analysis of Fever, Thrombocytopenia and Leukopenia Syndrome (FTLS) in Henan Province, China: Discovery of a New Bunyavirus , 2011, PLoS pathogens.

[20]  J. Kuhn,et al.  Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. , 2011, Antiviral research.

[21]  Weizhong Yang,et al.  Fever with thrombocytopenia associated with a novel bunyavirus in China. , 2011, The New England journal of medicine.

[22]  Teresa Blasco Máñez a structural perspective, , 2011 .

[23]  M. Bouloy,et al.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. , 2009, Antiviral research.

[24]  R. Elliott,et al.  RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. , 2008, Virology.

[25]  M. Habjan,et al.  T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. , 2008, The Journal of general virology.

[26]  S. Gerrard,et al.  The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. , 2007, Virology.

[27]  Shinji Makino,et al.  Rescue of Infectious Rift Valley Fever Virus Entirely from cDNA, Analysis of Virus Lacking the NSs Gene, and Expression of a Foreign Gene , 2006, Journal of Virology.

[28]  N. Ito,et al.  Improved Recovery of Rabies Virus from Cloned cDNA Using a Vaccinia Virus‐Free Reverse Genetics System , 2003, Microbiology and immunology.

[29]  R. Elliott,et al.  Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Pleschka,et al.  Negative-strand RNA viruses: genetic engineering and applications. , 1996, Proceedings of the National Academy of Sciences of the United States of America.